All published articles of this journal are available on ScienceDirect.

RESEARCH ARTICLE

Systemic Sclerosis and Abortion: Determining Factors and Clinical Significance in a Multicenter Study

Tamer A Gheita1 iD Hanan El-Saadany2 iD Fatma Ali3 iD Gehad Maghraby4 iD Nermeen Noshy5 iD Rawhya R El-Shereef3 iD Nesrin Aboeladl6 iD Eman F Mohamed7 iD Enas A Abdelaleem8 iD Samar Tharwat9 iD Khaled A Abdelgalil10 iD Thanaa F Mansour11 iD Asmaa Beltagy12 iD Yousra H Abdel-Fattah13 iD Gehad G Elsehrawy14 iD Nevin Hammam15 iD Ahmed Elsaman16 iD Iman I ElGazzar1 iD Nora Y Elsaid1 , * Open Modal iD Authors Info & Affiliations
The Open Rheumatology Journal 07 Sept 2026 RESEARCH ARTICLE DOI: 10.2174/0118743129492410260830101035

Abstract

Objective

The aim of this work was to identify disease-related factors associated with a history of spontaneous abortion in adult female patients with systemic sclerosis (SSc), and to further analyze the distinguishing features of SSc patients with recurrent versus single abortion episodes.

Materials and Methods

This multicenter case-control study was extracted from a nationwide SSc cohort of 1,080 patients. Ninety-one female adult SSc patients (8.4%) with a history of spontaneous abortion before 20 completed weeks of gestation were compared with 91 age-matched female SSc patients without a history of spontaneous abortion. Clinical characteristics, comorbidities, organ involvement, medications, and laboratory parameters were analyzed.

Results

Patients with spontaneous abortion had significantly longer disease duration (6.4±4.7 vs. 4.6±4.2 years; p=0.007), a higher prevalence of comorbidities (29.7% vs. 15.4%; p=0.03), more frequent telangiectasia (28.6% vs. 12.1%; p=0.009) and a higher frequency of mycophenolate mofetil use (29.7% vs. 15.4%; p=0.03) compared with patients without a history of spontaneous abortion. Recurrent spontaneous abortion occurred in 30 patients (33.0%). Compared with those with a single spontaneous abortion, patients with recurrent spontaneous abortion had significantly higher frequencies of Raynaud’s phenomenon (p<0.0001), hand puffiness (p=0.047), hypo-/hyperpigmentation (p=0.03), cardiovascular involvement (p=0.046), anti-Scl-70 positivity (p=0.01), double autoantibody positivity (p=0.017), and higher serum triglyceride levels (p=0.006).

Discussion

Patients with SSc have a higher risk of spontaneous abortion than the general population; this risk is likely driven by decidual vasculopathy and fibrosis. Factors contributing to spontaneous abortion were variable in previous reports, with hypertension and long disease duration among the most contributing factors.

Conclusion

In women with SSc, spontaneous abortion is associated with longer disease duration, telangiectasia, higher serum creatinine levels, the presence of comorbidities, and the use of MMF. Recurrent spontaneous abortion is associated with anti-Scl-70 positivity, double autoantibody positivity, and hypertriglyceridemia.

Keywords: Spontaneous abortion, Systemic sclerosis, Telangiectasia, Co-morbidities, Creatinine, Triglycerides.
Fulltext HTML PDF
1800
1801
1802
1803
1804